History | Nivolumab in combination with ipilimumab for treating advanced melanoma | Guidance | NICE

History

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 400 KB)

Published:

30 June 2016
Committee papers (PDF 18.28 MB)

Published:

25 April 2017

Invitation to participate

Final scope (PDF 112 KB)

Published:

09 November 2015
Final matrix (PDF 101 KB)

Published:

09 November 2015
Equality impact assessment (Scoping) (PDF 120 KB)

Published:

09 November 2015
NICE's response to comments on the draft scope and provisional matrix (PDF 349 KB)

Published:

02 December 2015

Provisional matrix (pre-referral) - March 2015

Provisional matrix (pre-referral) - March 2015 (PDF 103 KB)

Published:

03 August 2015

Melanoma (advanced, unresectable, metastatic) - nivolumab [ID846], [ID847], [ID848]: draft scope for consultation (pre-referral) - March 2015

Melanoma (advanced, unresectable, metastatic) - nivolumab [ID846], [ID847], [ID848]: draft scope for consultation (pre-referral) - March 2015 (PDF 133 KB)

Published:

03 August 2015